Atlas Capital Advisors LLC Astrazeneca PLC Transaction History

Atlas Capital Advisors LLC

$819 Billion
Q2 2025

A detailed history of Atlas Capital Advisors LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Atlas Capital Advisors LLC holds 3,940 shares of AZN stock, worth $296,839. This represents 0.03% of its overall portfolio holdings.

Number of Shares

3,940

Previous 4,240 7.08%

Holding current value

$296,839

Previous $312 Million 11.65%

% of portfolio

0.03%

Previous 0.04%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 12, 2025	SELL	$64.87 - $75.0 $19,461 - $22,500	-300 Reduced 7.08%	3,940 $275 Million
Q1 2025 May 12, 2025	BUY	$65.37 - $77.96 $9,282 - $11,070	142 Added 3.47%	4,240 $312 Million
Q4 2024 Feb 12, 2025	SELL	$63.2 - $79.58 $89,175 - $112,287	-1,411 Reduced 25.61%	4,098 $269 Million
Q3 2024 Nov 05, 2024	BUY	$76.67 - $87.62 $23,001 - $26,286	300 Added 5.76%	5,509 $429 Million
Q2 2024 Jul 29, 2024	SELL	$66.81 - $80.83 $33,204 - $40,172	-497 Reduced 8.71%	5,209 $406 Million
Q1 2024 Apr 15, 2024	SELL	$61.03 - $69.57 $163,987 - $186,934	-2,687 Reduced 32.01%	5,706 $387 Million
Q4 2023 Feb 15, 2024	SELL	$61.89 - $69.28 $33,730 - $37,757	-545 Reduced 6.1%	8,393 $565 Million
Q3 2023 Nov 14, 2023	SELL	$64.85 - $71.7 $17,314 - $19,143	-267 Reduced 2.9%	8,938 $605 Million
Q2 2023 Aug 15, 2023	SELL	$69.91 - $75.81 $9,158 - $9,931	-131 Reduced 1.4%	9,205 $659 Million
Q4 2022 Feb 15, 2023	SELL	$54.21 - $70.44 $211,852 - $275,279	-3,908 Reduced 29.51%	9,336 $633 Million
Q1 2022 May 11, 2022	BUY	$55.72 - $67.12 $14,208 - $17,115	255 Added 1.96%	13,244 $879 Million
Q4 2021 Feb 01, 2022	BUY	$54.02 - $63.83 $22,904 - $27,063	424 Added 3.37%	12,989 $757 Million
Q3 2021 Oct 28, 2021	BUY	$55.56 - $60.79 $48,559 - $53,130	874 Added 7.48%	12,565 $754,000
Q1 2021 May 10, 2021	SELL	$47.16 - $54.44 $27,116 - $31,303	-575 Reduced 4.69%	11,691 $581,000
Q4 2020 Feb 16, 2021	SELL	$48.52 - $58.02 $110,819 - $132,517	-2,284 Reduced 15.7%	12,266 $613,000
Q3 2020 Oct 23, 2020	SELL	$53.07 - $61.1 $69,627 - $80,163	-1,312 Reduced 8.27%	14,550 $797,000
Q2 2020 Jul 28, 2020	SELL	$43.1 - $55.31 $22,196 - $28,484	-515 Reduced 3.14%	15,862 $838,000
Q1 2020 May 04, 2020	SELL	$37.79 - $51.33 $15,493 - $21,045	-410 Reduced 2.44%	16,377 $731,000
Q4 2019 Jan 28, 2020	SELL	$42.46 - $50.46 $197,523 - $234,739	-4,652 Reduced 21.7%	16,787 $836,000
Q3 2019 Nov 01, 2019	BUY	$40.12 - $45.47 $26,278 - $29,782	655 Added 3.15%	21,439 $955,000
Q2 2019 Jul 25, 2019	BUY	$37.28 - $41.68 $20,914 - $23,382	561 Added 2.77%	20,784 $0
Q4 2018 Jan 29, 2019	SELL	$36.86 - $41.49 $281,536 - $316,900	-7,638 Reduced 27.41%	20,223 $768,000
Q3 2018 Nov 09, 2018	SELL	$34.76 - $39.72 $228,303 - $260,880	-6,568 Reduced 19.08%	27,861 $0
Q2 2018 Jul 30, 2018	BUY	$34.55 - $37.05 $1.19 Million - $1.28 Million	34,429 New	34,429 $0

Others Institutions Holding AZN

# of Institutions

1,413

Shares Held

506M

Call Options Held

9.17M

Put Options Held

3.07M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $233B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Atlas Capital Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Atlas Capital Advisors LLC with notifications on news.

Account

Atlas Capital Advisors LLC Astrazeneca PLC Transaction History